Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.
2.

Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet.

Yoshikawa T, Mitani K, Kotosai K, Nozako M, Miyakoda G, Yabuuchi Y.

Horm Metab Res. 2008 Jul;40(7):473-8. doi: 10.1055/s-2008-1065348. Epub 2008 Apr 10.

PMID:
18404599
3.

Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits.

Chen Y, Zhao S, Huang B, Wang Y, Li Y, Waqar AB, Liu R, Bai L, Fan J, Liu E.

Thromb Res. 2013 Nov;132(5):565-71. doi: 10.1016/j.thromres.2013.09.007. Epub 2013 Sep 13.

4.
5.

Combinatorial effect of probucol and cilostazol in focal ischemic mice with hypercholesterolemia.

Kim JH, Park SH, Bae SS, Hong KW, Kim YD, Park KP, Choi BT, Shin HK.

J Pharmacol Exp Ther. 2011 Aug;338(2):451-7. doi: 10.1124/jpet.111.181180. Epub 2011 May 5.

6.

Probucol plus cilostazol attenuate hypercholesterolemia‑induced exacerbation in ischemic brain injury via anti-inflammatory effects.

Kim JH, Hong KW, Bae SS, Shin YI, Choi BT, Shin HK.

Int J Mol Med. 2014 Sep;34(3):687-94. doi: 10.3892/ijmm.2014.1848. Epub 2014 Jul 10.

7.

The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.

El-Swefy S, Schaefer EJ, Seman LJ, van Dongen D, Sevanian A, Smith DE, Ordovas JM, El-Sweidy M, Meydani M.

Atherosclerosis. 2000 Apr;149(2):277-86.

PMID:
10729377
8.

Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin.

Keyamura Y, Nagano C, Kohashi M, Niimi M, Nozako M, Koyama T, Yasufuku R, Imaizumi A, Itabe H, Yoshikawa T.

PLoS One. 2014 May 8;9(5):e96929. doi: 10.1371/journal.pone.0096929. eCollection 2014.

9.

Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.

Goldberg RB, Rosenson RS, Hernandez-Triana E, Misir S, Jones MR.

J Clin Lipidol. 2012 Jul-Aug;6(4):318-24. doi: 10.1016/j.jacl.2012.05.005. Epub 2012 May 29.

PMID:
22836068
10.

Demonstration of an add-on effect of probucol and cilostazol on the statin-induced anti-atherogenic effects.

Wang Y, Bai L, Lin Y, Guan H, Zhu N, Chen Y, Li Y, Gao S, Zhao S, Fan J, Liu E.

Histol Histopathol. 2014 Dec;29(12):1593-600. doi: 10.14670/HH-29.1593. Epub 2014 Jul 31.

PMID:
25078428
11.
12.

Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits.

Wang Y, Bai L, Lin Y, Chen Y, Guan H, Zhu N, Li Y, Gao S, Sun L, Zhao S, Fan J, Liu E.

Lipids Health Dis. 2015 Jul 29;14:82. doi: 10.1186/s12944-015-0083-5.

13.

Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteers.

Kim KP, Kim BH, Lim KS, Kim TE, Shin SG, Jang IJ, Yu KS.

Clin Ther. 2009 Oct;31(10):2098-106. doi: 10.1016/j.clinthera.2009.10.005.

PMID:
19922880
14.

The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.

Atmeh RF, Stewart JM, Boag DE, Packard CJ, Lorimer AR, Shepherd J.

J Lipid Res. 1983 May;24(5):588-95.

15.

Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.

Andersen HO, Holm P, Nordestgaard BG, Hansen BF, Kjeldsen K, Elinder LS, Stender S.

J Mol Cell Cardiol. 1995 Aug;27(8):1561-71.

PMID:
8523419
17.

Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.

Masana L, Bargalló MT, Plana N, LaVille A, Casals I, Solà R.

Am J Cardiol. 1991 Oct 1;68(9):863-7.

PMID:
1927944
18.

Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis.

Sekiya M, Funada J, Watanabe K, Miyagawa M, Akutsu H.

Am J Cardiol. 1998 Jul 15;82(2):144-7.

PMID:
9678282
20.

Combined effect of atorvastatin and probucol on plasma cystatin C levels and severity of coronary lesion in patients with borderline coronary lesion.

Ge CJ, Lü SZ, Feng LX, Huo Y, Song XT, Chen X, Meng K, Yuan F.

Chin Med J (Engl). 2012 Jul;125(14):2472-6.

PMID:
22882924

Supplemental Content

Support Center